{"id":"W4416028285","doi":"10.1016/j.bneo.2025.100179","title":"Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood Neoplasia","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Bortezomib; Multiple myeloma; Proteasome; In vivo; Proteasome inhibitor; Cereblon; Cytotoxic T cell; Pomalidomide; Cell cycle","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001362077,0.0002776866,0.0005736426,0.0003226908,0.0001252289,0.000258915,0.0002216331,0.0002230581,0.001023893],"category_scores_gemma":[0.0001187189,0.0001185589,0.0002308635,0.0002602534,0.0001461349,0.0002098609,0.0002098861,0.0007323564,0.0002268951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002323645,"about_ca_system_score_gemma":0.0002573102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007327806,"about_ca_topic_score_gemma":0.001375216,"domain_scores_codex":[0.9998748,0.00002130099,0.00001141904,0.00002546989,0.00003016581,0.00003678838],"domain_scores_gemma":[0.9999409,0.000009306025,0.00001172918,0.000007354332,0.000004351674,0.00002641432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003081377,0.0007586944,0.0004674729,0.00008169482,0.00003235485,0.00007056187,0.00003172254,0.0006374068,0.9802688,0.0001056859,0.0002365844,0.01422762],"study_design_scores_gemma":[0.0006107422,0.01820894,0.008769799,0.00001148053,0.00008676155,0.0004322527,0.0000350101,0.001788489,0.9655092,0.00008447179,0.004448096,0.00001463724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966085,0.001827521,0.0004482758,0.00004759704,0.00003610936,0.00003345987,0.0001580619,0.00003950368,0.0008009244],"genre_scores_gemma":[0.9969912,0.000998984,0.0007345348,0.00003635679,0.00002183119,0.00002893572,0.0003132058,0.000009643149,0.0008652463],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001023893,"threshold_uncertainty_score":0.003425241,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.002477814032634891,"score_gpt":0.1963974673481172,"score_spread":0.1939196533154824,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}